C0127038.jpg

Professor Gert-Jan van Ommen (back), Dr Michael Gait at the Witness Seminar on ‘The Therapeutic Implications of Muscular Dystrophy Genomics’ held by the History of Modern Biomedicine Research Group, 27/10/2015

Tags: 

Duchenne muscular dystrophy
muscular dystrophy (MD)
genomics
clinical genetics
genomic medicine
creatine kinase (CK)
myopathy
polymorphism
DNA
chromosome
RNA
cDNA
Muscular Dystrophy Association
neurology
neurological disorder
geneticists
Witness Seminar